View Document Preview and Link Document Date: 2015-02-24 12:44:30 Open Document File Size: 2,80 MB Share Result on Facebook
City South San Francisco / / Company Amgen Inc. / Us Cytokinetics / Astellas Pharma Inc. / Cytokinetics / / Country United States / / Event Business Partnership / FDA Phase / / Facility University of San Francisco Memory / National Institute of Neurological Disorders / / IndustryTerm treatment of serious diseases / biopharmaceutical / treatment of heart failure / biological infrastructure / treatment of the disease / / MedicalCondition serious diseases / pneumonia / Lou Gehrig’s Disease / spinal muscular atrophy / disease / neurodegenerative disease / Neurological Disorders / dysfunction / ALS / Stroke / twitches of muscles / muscle weakness / AMYOTROPHIC LATERAL SCLEROSIS / fatigue / neuromuscular dysfunction / heart failure / diseases / muscle cramps / OF MOTOR NEURON DISEASE PATIENTS / / Organization Congress / European Medicines Agency / U.S. Food and Drug Administration / American Academy / 0RIMARY SYMPTOMS STIFFNESS SLOWNESS AND CLUMSINESS OF MOVEMENT / University of San Francisco / / Person Lou Gehrig / / Position physician / specialist / neurologist / / Product riluzole / Rilutek / Rilutek® (riluzole) / / ProvinceOrState California / / URL http / SocialTag 
AMYOTROPHIC LATERAL SCLEROSIS (ALS) (also known as Lou Gehrig’s Disease) DISEASE FACT SHEET AND OPPORTUNITY FOR TIRASEMTIV What is ALS? About Us Cytokinetics is a clinical-stage biopharmaceutical company